Best Castleman Disease Hospitals in Spain

Hospital Quironsalud Barcelona offers specialised Castleman Disease Treatment using modern diagnostic technology and established haematology treatment protocols. Established in 1944, the JCI, ISO accredited hospital is situated in Barcelona, Spain, with 165 beds, serving local and international patients.

Treatment is personalised according to the disease subtype, extent, symptoms, and underlying cause. Surgery may be recommended for unicentric disease when the affected lymph node can be safely removed, while multicentric forms may require targeted immunotherapy or other systemic medicines. Before treatment, the multidisciplinary team conducts imaging, lymph-node evaluation, blood tests, and other investigations to develop an appropriate treatment plan.

Hospital Ruber International offers advanced Castleman Disease Treatment using modern diagnostic and therapeutic approaches and internationally accepted treatment protocols. Established in 1982, the ISO accredited hospital is located in Madrid, Spain, with 345 beds, providing comprehensive care for local and international patients.

Treatment depends on the type of Castleman disease, number of affected lymph node regions, symptoms, and associated conditions. Localised unicentric disease may often be treated with surgical removal of the affected lymph node, while multicentric disease may require medicines such as immunotherapy, corticosteroids, or other systemic treatments. Detailed evaluation helps determine the appropriate approach.

At Jimenez Diaz Foundation University Hospital, patients can access comprehensive Castleman Disease Treatment supported by advanced diagnostic facilities and experienced specialists. Established in 1935, the ISO, JCI accredited hospital is located in Madrid, Spain, and has 686 beds.

Castleman disease treatment is tailored according to whether the condition is unicentric or multicentric and whether an underlying infection or immune disorder is present. Surgery may be used for localised disease, while multicentric forms may require antibody-based therapy, corticosteroids, chemotherapy, or treatment of an associated condition. A thorough diagnostic assessment guides treatment selection.

Quironsalud Marbella Hospital provides Castleman Disease Treatment using contemporary haematology and immunotherapy approaches, along with evidence-based care. Founded in 1979, the ISO accredited hospital is based in Marbella, Spain, with 120 beds and services for domestic and international patients.

The treatment approach depends on the subtype and severity of the disease. For unicentric Castleman disease, complete surgical removal may be sufficient in many cases. Multicentric disease may require systemic therapy, including medicines that target inflammatory pathways, corticosteroids, or other treatments based on the underlying cause and clinical presentation.

With advanced haematology and oncology infrastructure, Quironsalud Torrevieja Hospital offers Castleman Disease Treatment for patients requiring specialised management of this rare lymph-node disorder. Established in 2006, the ISO accredited hospital is located in Torrevieja, Spain, and has 119 beds.

For localised unicentric disease, treatment may involve surgical removal of the affected lymph node. Patients with multicentric disease may require systemic therapies, including anti-IL-6 therapy, other immunotherapies, corticosteroids, or chemotherapy in selected situations. Specialists assess lymph-node pathology, laboratory findings, symptoms, and associated infections or immune conditions before treatment.

At University Hospital Quironsalud Madrid, patients can access comprehensive Castleman Disease Treatment supported by advanced diagnostic facilities and experienced specialists. Established in 2006, the ISO, JCI accredited hospital is located in Madrid, Spain, and has 575 beds.

Castleman disease treatment is tailored according to whether the condition is unicentric or multicentric and whether an underlying infection or immune disorder is present. Surgery may be used for localised disease, while multicentric forms may require antibody-based therapy, corticosteroids, chemotherapy, or treatment of an associated condition. A thorough diagnostic assessment guides treatment selection.

With advanced haematology and oncology infrastructure, Dexeus University Hospital offers Castleman Disease Treatment for patients requiring specialised management of this rare lymph-node disorder. Established in 1973, the JCI accredited hospital is located in Barcelona, Spain, and has 200 beds.

For localised unicentric disease, treatment may involve surgical removal of the affected lymph node. Patients with multicentric disease may require systemic therapies, including anti-IL-6 therapy, other immunotherapies, corticosteroids, or chemotherapy in selected situations. Specialists assess lymph-node pathology, laboratory findings, symptoms, and associated infections or immune conditions before treatment.